Annual report
7730.TEDINET S100X59Q
Period2024-09-01 → 2025-08-31
Filed2025-11-18
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥30.0bn | 2024-09-01 → 2025-08-31 | Cons. | Net sales |
| Revenue | ¥28.5bn | 2023-09-01 → 2024-08-31 | Cons. | Net sales |
| Revenue | ¥24.5bn | 2022-09-01 → 2023-08-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.4bn | 2021-09-01 → 2022-08-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥17.2bn | 2020-09-01 → 2021-08-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥8.2bn | 2024-09-01 → 2025-08-31 | Cons. | Operating income |
| Operating income | ¥8.4bn | 2023-09-01 → 2024-08-31 | Cons. | Operating income |
| Ordinary income | ¥8.3bn | 2024-09-01 → 2025-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥8.5bn | 2023-09-01 → 2024-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥8.0bn | 2022-09-01 → 2023-08-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.5bn | 2021-09-01 → 2022-08-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.7bn | 2020-09-01 → 2021-08-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥7.1bn | 2024-09-01 → 2025-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥8.4bn | 2023-09-01 → 2024-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.6bn | 2024-09-01 → 2025-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.3bn | 2023-09-01 → 2024-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.0bn | 2022-09-01 → 2023-08-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.3bn | 2021-09-01 → 2022-08-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.3bn | 2020-09-01 → 2021-08-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥4.6bn | 2024-09-01 → 2025-08-31 | Cons. | Profit loss |
| Net income | ¥6.3bn | 2023-09-01 → 2024-08-31 | Cons. | Profit loss |
| Total assets | ¥58.0bn | at 2025-08-31 | Cons. | Assets |
| Total assets | ¥57.2bn | at 2024-08-31 | Cons. | Assets |
| Total assets | ¥55.0bn | at 2023-08-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥50.1bn | at 2022-08-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥42.7bn | at 2021-08-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.4bn | at 2025-08-31 | Cons. | Liabilities |
| Total liabilities | ¥4.8bn | at 2024-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥53.6bn | at 2025-08-31 | Cons. | Net assets |
| Net assets / equity | ¥52.3bn | at 2024-08-31 | Cons. | Net assets |
| Net assets / equity | ¥49.8bn | at 2023-08-31v | Cons. | Net assets |
| Net assets / equity | ¥45.4bn | at 2022-08-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥39.2bn | at 2021-08-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥18.4bn | at 2025-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥21.6bn | at 2024-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥17.4bn | at 2025-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.0bn | at 2024-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥23.8bn | at 2023-08-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.1bn | at 2022-08-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥18.1bn | at 2021-08-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥7.0bn | 2024-09-01 → 2025-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.8bn | 2023-09-01 → 2024-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.0bn | 2022-09-01 → 2023-08-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.6bn | 2021-09-01 → 2022-08-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.4bn | 2020-09-01 → 2021-08-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥7.2bn | 2024-09-01 → 2025-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥6.6bn | 2023-09-01 → 2024-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.0bn | 2022-09-01 → 2023-08-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2021-09-01 → 2022-08-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.4bn | 2020-09-01 → 2021-08-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥3.9bn | 2024-09-01 → 2025-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.7bn | 2023-09-01 → 2024-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.3bn | 2022-09-01 → 2023-08-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.4bn | 2021-09-01 → 2022-08-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.2bn | 2020-09-01 → 2021-08-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥47.14 | 2024-09-01 → 2025-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.82 | 2023-09-01 → 2024-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.46 | 2022-09-01 → 2023-08-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.75 | 2021-09-01 → 2022-08-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.6 | 2020-09-01 → 2021-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥543.76 | at 2025-08-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥531.18 | at 2024-08-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥505.88 | at 2023-08-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥461.41 | at 2022-08-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥398.29 | at 2021-08-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 92.4% | at 2025-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.5% | at 2024-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.6% | at 2023-08-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.6% | at 2022-08-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.8% | at 2021-08-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.8% | 2024-09-01 → 2025-08-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.3% | 2023-09-01 → 2024-08-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.5% | 2022-09-01 → 2023-08-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.5% | 2021-09-01 → 2022-08-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2020-09-01 → 2021-08-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 4,140 | at 2025-08-31 | Cons. | Number of employees |
| Employees | 4,154 | at 2024-08-31 | Cons. | Number of employees |
| Employees | 3,685 | at 2023-08-31v | Cons. | Number of employees |
| Employees | 3,417 | at 2022-08-31v | Cons. | Number of employees |
| Employees | 3,313 | at 2021-08-31d | Cons. | Number of employees |
| Revenue | ¥25.6bn | 2024-09-01 → 2025-08-31 | Standalone | Net sales |
| Revenue | ¥24.5bn | 2023-09-01 → 2024-08-31 | Standalone | Net sales |
| Revenue | ¥21.3bn | 2022-09-01 → 2023-08-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥17.6bn | 2021-09-01 → 2022-08-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥14.8bn | 2020-09-01 → 2021-08-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥6.7bn | 2024-09-01 → 2025-08-31 | Standalone | Operating income |
| Operating income | ¥7.2bn | 2023-09-01 → 2024-08-31 | Standalone | Operating income |
| Ordinary income | ¥6.8bn | 2024-09-01 → 2025-08-31 | Standalone | Ordinary income |
| Ordinary income | ¥7.4bn | 2023-09-01 → 2024-08-31 | Standalone | Ordinary income |
| Ordinary income | ¥6.2bn | 2022-09-01 → 2023-08-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.5bn | 2021-09-01 → 2022-08-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.7bn | 2020-09-01 → 2021-08-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥6.8bn | 2024-09-01 → 2025-08-31 | Standalone | Income before income taxes |
| Profit before tax | ¥7.3bn | 2023-09-01 → 2024-08-31 | Standalone | Income before income taxes |
| Net income | ¥4.8bn | 2024-09-01 → 2025-08-31 | Standalone | Profit loss |
| Net income | ¥5.4bn | 2023-09-01 → 2024-08-31 | Standalone | Profit loss |
| Net income | ¥4.5bn | 2022-09-01 → 2023-08-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥5.5bn | 2021-09-01 → 2022-08-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.4bn | 2020-09-01 → 2021-08-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥45.8bn | at 2025-08-31 | Standalone | Assets |
| Total assets | ¥44.7bn | at 2024-08-31 | Standalone | Assets |
| Total assets | ¥43.5bn | at 2023-08-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥41.3bn | at 2022-08-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥37.2bn | at 2021-08-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥4.0bn | at 2025-08-31 | Standalone | Liabilities |
| Total liabilities | ¥3.9bn | at 2024-08-31 | Standalone | Liabilities |
| Net assets / equity | ¥41.8bn | at 2025-08-31 | Standalone | Net assets |
| Net assets / equity | ¥40.8bn | at 2024-08-31 | Standalone | Net assets |
| Net assets / equity | ¥39.0bn | at 2023-08-31v | Standalone | Net assets |
| Net assets / equity | ¥37.5bn | at 2022-08-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥34.4bn | at 2021-08-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥8.7bn | at 2025-08-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥11.3bn | at 2024-08-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥48.87 | 2024-09-01 → 2025-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.78 | 2023-09-01 → 2024-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.69 | 2022-09-01 → 2023-08-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.9 | 2021-09-01 → 2022-08-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.98 | 2020-09-01 → 2021-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥39 | 2024-09-01 → 2025-08-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥39 | 2023-09-01 → 2024-08-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥35 | 2022-09-01 → 2023-08-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2021-09-01 → 2022-08-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥23 | 2020-09-01 → 2021-08-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥424.51 | at 2025-08-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥414.33 | at 2024-08-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥396.29 | at 2023-08-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥381.33 | at 2022-08-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥349.63 | at 2021-08-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 91.2% | at 2025-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.3% | at 2024-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.7% | at 2023-08-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.9% | at 2022-08-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.4% | at 2021-08-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.7% | 2024-09-01 → 2025-08-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.5% | 2023-09-01 → 2024-08-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2022-09-01 → 2023-08-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.3% | 2021-09-01 → 2022-08-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2020-09-01 → 2021-08-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 107,003,277 | at 2025-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 107,003,277 | at 2024-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,981,502 | at 2023-08-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,911,000 | at 2022-08-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,911,000 | at 2021-08-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 432 | at 2025-08-31 | Standalone | Number of employees |
| Employees | 403 | at 2024-08-31 | Standalone | Number of employees |
| Employees | 366 | at 2023-08-31v | Standalone | Number of employees |
| Employees | 350 | at 2022-08-31v | Standalone | Number of employees |
| Employees | 333 | at 2021-08-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 47
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2024-09-01 → 2025-08-31 | ¥222m |
| Reconciling Itemsreconciling | revenue | 2024-09-01 → 2025-08-31 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-09-01 → 2025-08-31 | −¥1m |
| Dental Related Productsreportable segment | depreciation | 2024-09-01 → 2025-08-31 | ¥940m |
| Dental Related Productsreportable segment | employees | at 2025-08-31 | 1106 pure |
| Dental Related Productsreportable segment | revenue | 2024-09-01 → 2025-08-31 | ¥9.5bn |
| Dental Related Productsreportable segment | revenue external | 2024-09-01 → 2025-08-31 | ¥9.5bn |
| Dental Related Productsreportable segment | segment profit | 2024-09-01 → 2025-08-31 | ¥1.1bn |
| Eyeless Needle Related Productsreportable segment | depreciation | 2024-09-01 → 2025-08-31 | ¥762m |
| Eyeless Needle Related Productsreportable segment | employees | at 2025-08-31 | 1728 pure |
| Eyeless Needle Related Productsreportable segment | revenue | 2024-09-01 → 2025-08-31 | ¥11.2bn |
| Eyeless Needle Related Productsreportable segment | revenue external | 2024-09-01 → 2025-08-31 | ¥11.2bn |
| Eyeless Needle Related Productsreportable segment | revenue intersegment | 2024-09-01 → 2025-08-31 | ¥1m |
| Eyeless Needle Related Productsreportable segment | segment profit | 2024-09-01 → 2025-08-31 | ¥4.0bn |
| Surgel Related Productsreportable segment | depreciation | 2024-09-01 → 2025-08-31 | ¥545m |
| Surgel Related Productsreportable segment | employees | at 2025-08-31 | 793 pure |
| Surgel Related Productsreportable segment | revenue | 2024-09-01 → 2025-08-31 | ¥9.3bn |
| Surgel Related Productsreportable segment | revenue external | 2024-09-01 → 2025-08-31 | ¥9.3bn |
| Surgel Related Productsreportable segment | segment profit | 2024-09-01 → 2025-08-31 | ¥3.1bn |
| —segment total | depreciation | 2024-09-01 → 2025-08-31 | ¥2.2bn |
| —segment total | revenue | 2024-09-01 → 2025-08-31 | ¥30.0bn |
| —segment total | revenue external | 2024-09-01 → 2025-08-31 | ¥30.0bn |
| —segment total | revenue intersegment | 2024-09-01 → 2025-08-31 | ¥1m |
| —segment total | segment profit | 2024-09-01 → 2025-08-31 | ¥8.2bn |
| Reconciling Itemsreconciling | revenue | 2023-09-01 → 2024-08-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-09-01 → 2024-08-31 | ¥0 |
| Dental Related Productsreportable segment | depreciation | 2023-09-01 → 2024-08-31 | ¥1.0bn |
| Dental Related Productsreportable segment | revenue | 2023-09-01 → 2024-08-31 | ¥10.1bn |
| Dental Related Productsreportable segment | revenue external | 2023-09-01 → 2024-08-31 | ¥10.1bn |
| Dental Related Productsreportable segment | segment profit | 2023-09-01 → 2024-08-31 | ¥1.9bn |
| Eyeless Needle Related Productsreportable segment | depreciation | 2023-09-01 → 2024-08-31 | ¥776m |
| Eyeless Needle Related Productsreportable segment | revenue | 2023-09-01 → 2024-08-31 | ¥10.2bn |
| Eyeless Needle Related Productsreportable segment | revenue external | 2023-09-01 → 2024-08-31 | ¥10.2bn |
| Eyeless Needle Related Productsreportable segment | revenue intersegment | 2023-09-01 → 2024-08-31 | ¥0 |
| Eyeless Needle Related Productsreportable segment | segment profit | 2023-09-01 → 2024-08-31 | ¥3.9bn |
| Surgel Related Productsreportable segment | depreciation | 2023-09-01 → 2024-08-31 | ¥484m |
| Surgel Related Productsreportable segment | revenue | 2023-09-01 → 2024-08-31 | ¥8.2bn |
| Surgel Related Productsreportable segment | revenue external | 2023-09-01 → 2024-08-31 | ¥8.2bn |
| Surgel Related Productsreportable segment | segment profit | 2023-09-01 → 2024-08-31 | ¥2.6bn |
| —segment total | depreciation | 2023-09-01 → 2024-08-31 | ¥2.3bn |
| —segment total | revenue | 2023-09-01 → 2024-08-31 | ¥28.5bn |
| —segment total | revenue external | 2023-09-01 → 2024-08-31 | ¥28.5bn |
| —segment total | revenue intersegment | 2023-09-01 → 2024-08-31 | ¥0 |
| —segment total | segment profit | 2023-09-01 → 2024-08-31 | ¥8.4bn |
| Dental Related Productsreportable segment | employees | at 2025-08-31 | 113 pure |
| Eyeless Needle Related Productsreportable segment | employees | at 2025-08-31 | 70 pure |
| Surgel Related Productsreportable segment | employees | at 2025-08-31 | 118 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,559
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior2YearInstant | 54977000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 57177000000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 57987000000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 398.29 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 461.41 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 505.88 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 531.18 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 543.76 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 43.60 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 53.75 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 60.46 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 63.82 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 47.14 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.918 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.906 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.906 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.915 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.924 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.113 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.125 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.125 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.123 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.088 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | 49.9 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | 32.7 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 31.4 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 30.8 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 26.2 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 6384000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 6559000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | 8026000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 7810000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 7017000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -3438000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -2173000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -4016000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -6642000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -7154000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -2232000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -2444000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -3251000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -3703000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -3895000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 18057000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 22084000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |